Schedule 13G ownership disclosure

Benitec Biopharma Inc

Security class unavailable · CUSIP: 08205P209

Event date: 2024-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,682,275
Percent of class
13.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-24-000083
Form type
SC 13G/A
Filer
Benitec Biopharma Inc.
CIK
CIK 1808898
Filed
Nov 06, 2024
Reporting period
Oct 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub